Clinical Trials Browser

INDUSTRY × Breast Neoplasms × Gene Expression Profiling × Clear all

NCT03521245 2021-09-14

Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer

Breast Neoplasms